Surgical & Medical Instruments & Apparatus
Standard Industrial Classification: SIC 3841
Industry Insider Sentiment Analysis
The Surgical & Medical Instruments & Apparatus sector (SIC 3841) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.
| Filing Date | Trade Date | Ticker | Company | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After |
|---|---|---|---|---|---|---|---|---|---|---|
| 2022-01-03 22:04 | 2021-12-30 | DCTH | DELCATH SYSTEMS, INC. | SALAMON STEVEN A J | Director | BUY | $7.56 | 2,000 | $15,120 | 421,500 |
| 2022-01-03 22:02 | 2021-12-30 | DCTH | DELCATH SYSTEMS, INC. | Rosalind Advisors, Inc. | Director | BUY | $7.56 | 2,000 | $15,120 | 423,500 |
| 2022-01-04 01:00 | 2021-12-30 | ATAO | Premier Air Charter Holdings Inc. | Lovallo Leonard | Director, Officer | SELL | $0.03 | 150,000 | $4,110 | 29,280,000 |
| 2022-01-03 23:41 | 2021-12-29 | CMXC | Stimcell Energetics Inc. | HARGREAVES BRADLEY S | Director, Officer, 10% owner | SELL | $0.18 | 5,000 | $923 | 5,496,747 |
| 2022-01-04 00:45 | 2021-12-27 | NXGL | NEXGEL, INC. | Toledano Miranda Jayne | Director | BUY | $5.49 | 1,819 | $9,986 | 1,819 |
| 2022-01-04 00:44 | 2021-12-27 | NXGL | NEXGEL, INC. | glassman steven mark | Director | BUY | $5.49 | 5,000 | $27,450 | 109,592 |
| 2022-01-04 00:46 | 2021-12-27 | NXGL | NEXGEL, INC. | ZELDIS JEROME B | Director | BUY | $5.49 | 9,091 | $49,910 | 82,728 |
| 2022-01-04 00:44 | 2021-12-27 | NXGL | NEXGEL, INC. | STEFANSKY DAVID | Director | BUY | $5.49 | 9,091 | $49,910 | 9,091 |
| 2022-01-04 04:00 | 2021-12-29 | CTSO | Cytosorbents Corp | Chan Phillip P. | Officer | BUY | $4.05 | 15,000 | $60,749 | 768,443 |
| 2022-01-04 00:45 | 2021-12-27 | NXGL | NEXGEL, INC. | STEIN NACHUM | Director | BUY | $5.49 | 28,000 | $153,720 | 476,358 |
| 2021-12-31 02:01 | 2021-12-28 | TMCI | TREACE MEDICAL CONCEPTS, INC. | Treace John T. | Director, Officer, 10% owner | SELL | $17.00 | 22,835 | $388,117 | 5,422,580 |
| 2021-12-31 00:59 | 2021-12-28 | ICUI | ICU MEDICAL INC/DE | Jain Vivek | Director, Officer | OPT+S | $240.00 | 12,000 | $2,880,013 | 12,779 |
| 2021-12-31 01:53 | 2021-12-29 | INFU | InfuSystem Holdings, Inc | RUIZ THOMAS MARK | Officer | SELL | $17.00 | 76 | $1,292 | 16,980 |
| 2021-12-31 02:00 | 2021-12-28 | TMCI | TREACE MEDICAL CONCEPTS, INC. | TREACE JAMES T | Director | SELL | $16.88 | 1,563 | $26,387 | 2 |
| 2021-12-30 17:00 | 2021-12-28 | NSPR | InspireMD, Inc. | ROUBIN GARY S | Director | BUY | $3.08 | 16,393 | $50,436 | 128,694 |
| 2021-12-30 00:33 | 2021-12-28 | BSX | BOSTON SCIENTIFIC CORP | Meredith Ian T | Officer | SELL | $43.21 | 7,018 | $303,248 | 26,243 |
| 2021-12-30 00:37 | 2021-12-27 | TFX | TELEFLEX INC | Kelly Liam | Director, Officer | OPT+S | $330.00 | 8,987 | $2,965,710 | 25,775 |
| 2021-12-30 00:42 | 2021-12-27 | TNDM | TANDEM DIABETES CARE INC | Gasser Elizabeth Anne | Officer | OPT+S | $151.36 | 1,084 | $164,075 | 431 |
| 2021-12-30 00:29 | 2021-12-27 | TNDM | TANDEM DIABETES CARE INC | Leal James | Officer | OPT+S | $151.45 | 1,906 | $288,666 | 4,008 |
| 2021-12-30 01:57 | 2021-12-27 | LMAT | LEMAITRE VASCULAR INC | Pellegrino Joseph P JR | Director, Officer | OPT+S | $52.00 | 807 | $41,964 | 8,848 |
| 2021-12-29 01:32 | 2021-12-23 | INSP | Inspire Medical Systems, Inc. | Ban Randy | Officer | OPT+S | $240.00 | 9,760 | $2,342,400 | 248 |
| 2021-12-29 00:35 | 2021-12-27 | IRMD | IRADIMED CORP | Susi Roger E. | Director, Officer, 10% owner | SELL | $47.11 | 10,000 | $471,073 | 826,050 |
| 2021-12-28 04:10 | 2021-12-22 | TMCI | TREACE MEDICAL CONCEPTS, INC. | Treace John T. | Director, Officer, 10% owner | SELL | $16.72 | 81,670 | $1,365,269 | 5,445,415 |
| 2021-12-28 00:15 | 2021-12-22 | XAIR | Beyond Air, Inc. | Carey Robert | Director | BUY | $9.50 | 10,000 | $95,000 | 518,418 |
| 2021-12-28 04:09 | 2021-12-22 | TMCI | TREACE MEDICAL CONCEPTS, INC. | TREACE JAMES T | Director | SELL | $16.64 | 42,437 | $706,241 | 1,565 |
| 2021-12-24 01:59 | 2021-12-21 | BEAT | HeartBeam, Inc. | BROUNSTEIN RICHARD D | Officer | BUY | $3.37 | 5,000 | $16,846 | 102,075 |
| 2021-12-24 01:29 | 2021-12-23 | DXCM | DEXCOM INC | Pacelli Steven Robert | Officer | SELL | $573.91 | 250 | $143,478 | 34,870 |
| 2021-12-23 03:05 | 2021-12-20 | TMCI | TREACE MEDICAL CONCEPTS, INC. | Treace John T. | Director, Officer, 10% owner | SELL | $15.98 | 60,495 | $966,438 | 5,527,085 |
| 2021-12-23 01:43 | 2021-12-20 | TELA | TELA Bio, Inc. | EW HEALTHCARE PARTNERS FUND 2, L.P. | BUY | $12.22 | 4,300 | $52,546 | 1,900,300 | |
| 2021-12-23 00:41 | 2021-12-21 | IRMD | IRADIMED CORP | Susi Roger E. | Director, Officer, 10% owner | SELL | $44.38 | 10,000 | $443,800 | 836,050 |
| 2021-12-23 03:03 | 2021-12-20 | TMCI | TREACE MEDICAL CONCEPTS, INC. | TREACE JAMES T | Director | SELL | $15.91 | 31,000 | $493,346 | 44,002 |
| 2021-12-22 03:19 | 2021-12-17 | GBS | INTELLIGENT BIO SOLUTIONS INC. | Life Science Biosensor Diagnostics Pty Ltd | 10% owner | SELL | $1.49 | 200,000 | $298,000 | 2,757,832 |
| 2021-12-22 00:33 | 2021-12-20 | BSX | BOSTON SCIENTIFIC CORP | Pierce David A | Officer | OPT+S | $39.90 | 49,988 | $1,994,621 | 0 |
| 2021-12-21 21:06 | 2021-12-20 | CMXC | Stimcell Energetics Inc. | HARGREAVES BRADLEY S | Director, Officer, 10% owner | SELL | $18.20 | 5,000 | $91,000 | 5,501,747 |
| 2021-12-21 05:00 | 2021-12-16 | GBS | INTELLIGENT BIO SOLUTIONS INC. | Parmakellis Tom | Director | BUY | $1.69 | 2,800 | $4,732 | 4,800 |
| 2021-12-21 03:11 | 2021-12-16 | VERO | Venus Concept Inc. | PORTARO ROSS | Officer | BUY | $1.35 | 20,000 | $27,000 | 50,000 |
| 2021-12-20 20:28 | 2021-12-16 | ATEC | Alphatec Holdings, Inc. | Koning John Todd | Officer | BUY | $11.17 | 5,000 | $55,850 | 196,682 |
| 2021-12-18 01:40 | 2021-12-15 | TELA | TELA Bio, Inc. | EW HEALTHCARE PARTNERS FUND 2, L.P. | BUY | $12.44 | 10,050 | $125,022 | 1,896,000 | |
| 2021-12-17 21:50 | 2021-12-15 | SRTS | Sensus Healthcare, Inc. | Cohen Stephen Brad | Officer | SELL | $7.04 | 47,345 | $333,224 | 830,585 |
| 2021-12-17 22:34 | 2021-12-15 | CMXC | Stimcell Energetics Inc. | HARGREAVES BRADLEY S | Director, Officer, 10% owner | SELL | $0.19 | 4,654 | $884 | 5,506,747 |
| 2021-12-17 19:23 | 2021-12-15 | RMD | RESMED INC | Farrell Michael J. | Officer | OPT+S | $255.53 | 5,675 | $1,450,141 | 405,229 |
| 2021-12-18 01:35 | 2021-12-15 | TNDM | TANDEM DIABETES CARE INC | BERGER DAVID B | Officer | OPT+S | $144.25 | 12,000 | $1,731,000 | 4,451 |
| 2021-12-18 00:17 | 2021-12-15 | VERO | Venus Concept Inc. | Sullivan Keith J | Director | BUY | $1.25 | 80,000 | $100,000 | 80,000 |
| 2021-12-18 00:15 | 2021-12-15 | VERO | Venus Concept Inc. | Kong Garheng | Director, 10% owner | BUY | $1.25 | 1,600,000 | $2,000,000 | 6,795,621 |
| 2021-12-18 05:45 | 2021-12-15 | VERO | Venus Concept Inc. | EW Healthcare Partners, L.P. | 10% owner | BUY | $1.25 | 3,920,000 | $4,900,000 | 16,337,856 |
| 2021-12-18 01:28 | 2021-12-15 | VERO | Venus Concept Inc. | HealthQuest Partners II, L.P. | 10% owner | BUY | $1.25 | 1,600,000 | $2,000,000 | 6,795,621 |
| 2021-12-18 05:31 | 2021-12-15 | VERO | Venus Concept Inc. | BARRY RICHARD SCOTT | Director, 10% owner | BUY | $1.25 | 3,920,000 | $4,900,000 | 16,337,856 |
| 2021-12-17 19:24 | 2021-12-15 | RMD | RESMED INC | Douglas Robert Andrew | Officer | OPT+S | $256.52 | 8,000 | $2,052,160 | 17,175 |
| 2021-12-17 21:48 | 2021-12-15 | SRTS | Sensus Healthcare, Inc. | Sardano Joseph C | Director, Officer | SELL | $7.00 | 24,227 | $169,637 | 1,463,649 |
| 2021-12-18 01:51 | 2021-12-15 | TMCI | TREACE MEDICAL CONCEPTS, INC. | TREACE JAMES T | Director | SELL | $16.06 | 75,000 | $1,204,643 | 1,055,258 |
Sector-Wide Insider Alpha
Analyzing insider movements across the Surgical & Medical Instruments & Apparatus sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (3841) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.
SEC Filings in Surgical & Medical Instruments & Apparatus
Every transaction in the Surgical & Medical Instruments & Apparatus industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.